Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,358,000 | 1,539,000 | 4,644,000 | 8,480,000 | 5,768,000 |
| Depreciation Amortization | 713,000 | 357,000 | 1,286,000 | 889,000 | 592,000 |
| Income taxes - deferred | -2,000 | 35,000 | -82,000 | 127,000 | 138,000 |
| Accounts receivable | 277,000 | 101,000 | 754,000 | 473,000 | 118,000 |
| Accounts payable and accrued liabilities | -193,000 | -92,000 | -430,000 | -515,000 | -399,000 |
| Other Working Capital | -847,000 | 70,000 | 5,108,000 | -882,000 | -427,000 |
| Other Operating Activity | 537,000 | 260,000 | 618,000 | 573,000 | 661,000 |
| Operating Cash Flow | $3,843,000 | $2,270,000 | $11,898,000 | $9,145,000 | $6,451,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,206,000 | 4,586,000 | -5,053,000 | -5,683,000 | -3,698,000 |
| PPE Investments | -509,000 | -212,000 | -590,000 | -370,000 | -241,000 |
| Net Acquisitions | N/A | N/A | -10,426,000 | N/A | N/A |
| Other Investing Activity | -102,000 | -20,000 | 0 | 0 | 0 |
| Investing Cash Flow | $9,595,000 | $4,354,000 | $-16,069,000 | $-6,053,000 | $-3,939,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 8,985,000 | 2,991,000 | N/A |
| Debt Repayment | -4,500,000 | -4,500,000 | -1,811,000 | -90,000 | -60,000 |
| Common Stock Issued | 159,000 | 111,000 | 234,000 | 183,000 | 119,000 |
| Common Stock Repurchased | -1,489,000 | -1,039,000 | -954,000 | -848,000 | -695,000 |
| Dividend Paid | -1,493,000 | -753,000 | -2,731,000 | -2,049,000 | -1,367,000 |
| Other Financing Activity | -424,000 | -414,000 | -330,000 | -141,000 | -121,000 |
| Financing Cash Flow | $-7,747,000 | $-6,595,000 | $3,393,000 | $46,000 | $-2,124,000 |
| Exchange Rate Effect | -45,000 | 26,000 | 137,000 | 141,000 | 95,000 |
| Beginning Cash Position | 7,588,000 | 7,588,000 | 8,229,000 | 8,229,000 | 8,229,000 |
| End Cash Position | 13,234,000 | 7,643,000 | 7,588,000 | 11,508,000 | 8,712,000 |
| Net Cash Flow | $5,646,000 | $55,000 | $-641,000 | $3,279,000 | $483,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,843,000 | 2,270,000 | 11,898,000 | 9,145,000 | 6,451,000 |
| Capital Expenditure | -509,000 | -212,000 | -590,000 | -370,000 | -241,000 |
| Free Cash Flow | 3,334,000 | 2,058,000 | 11,308,000 | 8,775,000 | 6,210,000 |